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Cultured skin substitutes have become useful as
adjunctive treatments for excised, full-thickness
burns, but no skin substitutes have the anatomy and
physiology of native skin. Hypothetically, de®cien-
cies of structure and function may result, in part,
from nutritional de®ciencies in culture media. To
address this hypothesis, vitamin C was titrated at 0.0,
0.01, 0.1, and 1.0 mM in a cultured skin substitute
model on ®lter inserts. Cultured skin substitute
inserts were evaluated at 2 and 5 wk for viability by
incorporation of 5-bromo-2¢-deoxyuridine (BrdU)
and by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tet-
razolium bromide (MTT) conversion. Subsequently,
cultured skin substitute grafts consisting of cultured
human keratinocytes and ®broblasts attached to col-
lagen-glycosaminoglycan substrates were incubated
for 5 wk in media containing 0.0 mM or 0.1 mM
vitamin C, and then grafted to athymic mice.
Cultured skin substitutes (n = 3 per group) were
evaluated in vitro at 2 wk of incubation for collagen
IV, collagen VII, and laminin 5, and through 5 wk
for epidermal barrier by surface electrical capaci-
tance. Cultured skin substitutes were grafted to full-
thickness wounds in athymic mice (n = 8 per group),
evaluated for surface electrical capacitance through
6 wk, and scored for percentage original wound area
through 8 wk and for HLA-ABC-positive wounds at
8 wk after grafting. The data show that incubation of
cultured skin substitutes in medium containing vita-
min C results in greater viability (higher BrdU and
MTT), more complete basement membrane devel-
opment at 2 wk, and better epidermal barrier (lower
surface electrical capacitance) at 5 wk in vitro. After
grafting, cultured skin substitutes with vitamin C
developed functional epidermal barrier earlier, had
less wound contraction, and had more HLA-positive
wounds at 8 wk than without vitamin C. These
results suggest that incubation of cultured skin sub-
stitutes in medium containing vitamin C extends cel-
lular viability, promotes formation of epidermal
barrier in vitro, and promotes engraftment. Improved
anatomy and physiology of cultured skin substitutes
that result from nutritional factors in culture media
may be expected to improve ef®cacy in treatment of
full-thickness skin wounds. Key words: ascorbic acid/
wound healing/stratum corneum/skin grafts. J Invest
Dermatol 118:565±572, 2002
E
ffective treatment of full-thickness skin wounds requires
restoration of a functional and stable epidermal barrier.
Many approaches to restoration of epidermal barrier
have been described, including skin substitutes prepared
from autologous or allogeneic cultured keratinocytes
(Green et al, 1979; Bell et al, 1981; Bell and Rosenberg, 1990;
Beumer et al, 1993; Boyce, 1996; Berthod and Damour, 1997). A
general de®ciency of cultured keratinocytes has been failure to form
functional epidermal barrier in vitro (Mak et al, 1991; Ponec and
Kempenaar, 1995), and the coincident accumulation of triglycer-
ides (Ponec et al, 1995). However, cultured keratinocytes form a
barrier after transplantation, to close wounds (Boyce et al, 1996;
Goretsky et al, 1995). Hypothetically, cultured skin substitutes
(CSS) that form in vitro an epidermal barrier that is homologous
anatomically and physiologically with uninjured human skin may
promote more ef®cacious and more rapid wound closure.
Epidermal barrier results from anabolic metabolism of carbohy-
drate into a variety of specialized lipids that form a liquid-crystal
matrix among corneocytes in the stratum corneum (Wertz and
Downing, 1991). Failure to form a barrier may be assumed to be
caused by errors in keratinocyte metabolism in the pathways of
carbohydrate to lipid, particularly in the formation of complex
ceramides. Critical to the formation of barrier lipids is the
esteri®cation of ceramides with essential fatty acids in the pathway
to synthesis of acyl-glucosyl-ceramides (Wertz and Downing,
1991). The esteri®cation reaction requires hydroxylation of the
methyl ends of fatty acids as a precursor to the addition of essential
fatty acids. A recent study by Holleran and colleagues (Behne et al,
2001) showed that blocking of the hydroxylation reaction during
synthesis of fatty acids in keratinocytes blocked the synthesis of the
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specialized lipids that are required for epidermal barrier. De®nitive
studies by Ponec et al (1997) showed that the formation of barrier
lipids in CSS is greatly enhanced by the presence of ascorbic acid
and linoleic acid in the incubation medium. The enhancement of
epidermal barrier by vitamin C agrees very well with the
requirement for vitamin C in hydroxylation reactions during
collagen synthesis to form connective tissue (Kivirikko and
Kiuvaniemi, 1987; Wenstrup et al, 1991). Similarly, vitamin C
has been shown to stimulate the growth of cultured rabbit corneal
keratinocytes (Saika et al, 1991). These examples of the multiple
activities of vitamin C represent the importance of this cofactor in
both general and speci®c metabolic pathways.
Anatomic and physiologic de®ciencies of cultured cells for
transplantation result from de®ciencies in culture conditions,
perhaps the most important of which is medium formulation.
Although vitamins are essential for proper nutrition (Bettger and
Ham, 1982; Bettger and McKeehan, 1986), conventional media
provide predominantly B vitamins for energy production. Other
vitamins that are required for specialized cellular phenotypes,
however (e.g., vitamins A, D, K), are usually not components of
standard media for reasons of solubility or stability. Rather, some
vitamins are derived from tissue extracts, such as sera, which are
added to basal media. Consequently, de®ned media will exaggerate
nutritional de®ciencies from absence of vitamins from sources such
as sera, but also are more responsive to factors that regulate cellular
proliferation and differentiation (Ham and McKeehan, 1979).
Therefore, the nutritional composition of de®ned media must
provide a full complement of factors that may otherwise be
provided by tissue extracts. In addition to growth factors (e.g.,
epidermal growth factor, Keratinocyte Growth Factor (KGF),
insulin-like growth factor 1) that are required to promote mitosis in
the absence of tissue extracts, both essential nutrients and vitamins
can limit or promote growth in de®ned media (Ham and
McKeehan, 1979; McKeehan, 1982). Historically, media that
stimulate rapid proliferation of keratinocytes in serum-free or
de®ned conditions have contained neither essential fatty acids nor
vitamin C (Boyce and Ham, 1983; Pittelkow and Scott, 1986;
Shipley and Pittelkow, 1987).
Previous studies from this laboratory have described nutritional
requirements for cultured keratinocytes (Boyce and Ham, 1985),
stimulation of barrier lipids by addition of lipid supplements to the
culture medium (Boyce and Williams, 1993), measurement of
epidermal barrier with noninvasive biophysical measurements
(Boyce et al, 1996), regulation of keratinocyte growth and
differentiation by essential nutrients (Boyce et al, 1993a) and by
insulin (Swope et al, 2001), and healing of burns and chronic
wounds with CSS (Hansbrough et al, 1989; Boyce et al, 1995a;
1995b; 1999; 2002). This study investigated whether supplementa-
tion with vitamin C of media for maturation and differentiation of
keratinocytes in CSS affects the viability and stability of the grafts
in vitro, and their ef®cacy for closure of full-thickness cutaneous
wounds. Hypothetically, an increase of viability and stability in vitro
may increase the therapeutic ef®cacy of cultured skin grafts,
contribute to more rapid and complete healing of cutaneous
wounds with transplanted cells, and extend the incubation time for
which cultured skin grafts may be applied with con®dence of
favorable outcome.
MATERIALS AND METHODS
Cell culture Human keratinocytes and ®broblasts were coisolated from
surgical discard tissue using selective growth media and cryopreserved at
passage 1 for these experiments (Boyce and Ham, 1983; 1985). Two
formats of cell culture were used for two purposes. Cell culture inserts
were prepared in six-well dishes to titrate an optimal concentration of
vitamin C into the incubation medium. After an optimal concentration of
vitamin C was determined, CSS grafts were prepared with and without
the optimal concentration of vitamin C for assessment in vitro and for
grafting to full-thickness surgical wounds.
Cell culture insert preparation A cultured skin model was developed
using a collagen-glycosaminoglycan (GAG) substrate inoculated with
human ®broblasts at 5 3 105 per cm2. Human keratinocytes were
inoculated at 8.3 3 105 per cm2 into Costar polycarbonate Transwell
inserts, and designated as incubation day 0. Dulbecco's modi®ed Eagle's
medium (DMEM) (1.8 mM calcium) supplemented as reported by Chen
et al (1995) with modi®cations was used beginning on day 0 for the
human keratinocyte insert inoculation with the following test conditions:
0.0, 0.01, 0.1, or 1.0 mM vitamin C. On day 1, the insert membrane
was removed from the plastic support and combined with the human
®broblast inoculated collagen disks in the DMEM test media. Each
human ®broblast collagen disk and human keratinocyte insert membrane
was lifted to the air±liquid interface on day 3 as a unit with the insert
membrane overlying the human ®broblast collagen disk. The vitamin C
(Sigma Chemical, St. Louis, MO) was prepared daily in the test medium.
Four paired human ®broblast/human keratinocyte cell strains were
inoculated onto two to three collagen-insert units per cell strain (n = 10
per condition). Samples were collected weekly for histologies, and at
days 14 and 35 for the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide (MTT) assay and incorporation of 5-bromo-2¢-
deoxyuridine (BrdU). For light microscopy, biopsies of the insert model
were ®xed in 10% buffered neutral formalin, embedded in paraf®n,
sectioned, and stained with hematoxylin and eosin.
CSS graft preparation CSS (n = 3 per condition) were prepared by
sequential inoculation with human ®broblasts (5 3 105 per cm2) and
human keratinocytes (1 3 106 per cm2) onto acellular collagen-GAG
biopolymer substrates as previously described (Boyce et al, 1991) with
the following modi®cations. On day 3 after human keratinocyte
inoculation, the CSS were lifted and maintained at the air±liquid
interface in saturated relative humidity at 37°C and 5% CO2 (Boyce and
Williams, 1993). Vitamin C (0.0 and 0.1 mM) was prepared fresh and
replaced daily for 5 wk. Samples were collected at 2 wk for
immunohistochemistry, and at 5 wk for light microscopy and assay of
MTT conversion.
CSS grafting to athymic mice All animal studies were conducted
according to the guidelines established by the National Institutes of
Health, with the approval of the University of Cincinnati Institutional
Animal Care and Use Committee. On culture day 35, CSS incubated in
media containing 0.0 mM vitamin C (n = 8) or 0.1 mM vitamin C
(n = 9) were grafted orthotopically to 2 3 2 cm skin wounds prepared
surgically (Boyce et al, 1991; Boyce, 1998) in athymic mice (nu/nc;
Harlan, Indianapolis, IN). Wounds were prepared leaving the panniculus
carnosus intact and the CSS (»4 cm2) were sutured in place with an
overlay of nonadherent dressing (N-Terface; Win®eld Laboratories,
Richardson, TX). The wounds were dressed as previously described
(Supp et al, 2000) and left undisturbed for 2 wk. On day 14 after
surgery, dressings and stent sutures were removed, data were collected,
and mice were re-bandaged with N-Terface, cotton gauze, and Coban
(3M Medical Division, St. Paul, MN). All dressings were removed on
day 21 for the remainder of the in vivo study period.
MTT assay Six millimeter punch biopsies were collected on days 14
and 35 (n = 10 CSS inserts per condition; 24±48 punches per condition)
and on day 35 only (n = 3 CSS grafts per condition; 12±18 punches per
condition). Biopsies were incubated for 3 h at 37°C with 0.5 mg per ml
MTT (Sigma Chemical). The mitochondria of viable cells cleave the
tetrazolium salt MTT to formazan (Mosmann, 1983; Swope et al, 2001).
The MTT±formazan reaction product was released by incubating the
biopsies in 2-methoxy-ethanol for 3 h on a rotating platform. The
optical density of the MTT±formazan product was read at 590 nm on a
microplate reader (Cambridge Technologies, Watertown, MA).
BRDU incorporation Biopsies (1 cm2) from the collagen-insert unit
were incubated for 22 h with 65 mM BrdU (Roche Molecular
Biochemicals, Indianapolis, IN) in a lifted format on day 28. The BrdU-
labeled tissue was ®xed in 10% buffered neutral formalin and processed
for paraf®n embedding. The tissue sections were deparaf®nized and
rehydrated in graded alcohols. Three 0.01 M phosphate-buffered saline
(PBS) washes were performed between the labeling steps outlined below
and all solutions were prepared in the same buffer. The sections were
partially digested with 0.025% trypsin for 20 min at 37°C followed by
2% bovine serum albumin to inactivate the trypsin. The cellular DNA
was denatured with 1.5 N HCl for 15 min at 37°C and then neutralized
with 0.1 M sodium tetraborate. Following a blocking step, the sections
were incubated with murine anti-BrdU-FITC (Becton-Dickinson, San
Jose, CA) at 4°C overnight, and counterstained with propidium iodide
(5 mg per ml). The slides were coverslipped with Fluoromount G
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(Southern Biotechnology Associates, Birmingham, AL). The BrdU-
FITC-positive and propidium-iodide-labeled nuclei in cells attached to
the ®lter membrane were counted per microscopic ®eld (®eld length
550 mm). Four to six unique sections were counted per sample (n = 8
collagen-insert units per condition) at the day 14 and day 35 time point.
The percentage of BrdU-positive human keratinocytes was calculated by
dividing the BrdU-FITC-positive human keratinocytes by the
propidium-iodide-labeled nuclei 3 100.
Transmission electron microscopy (TEM) TEM was performed to
identify multilamellar lipids of the stratum corneum. Strati®ed epithelia
on Millipore inserts were ®xed with 2% glutaraldehyde in 0.1 M sodium
cacodylate buffer, followed by post®xation for 2 h in aqueous 1%
osmium tetroxide and 0.25% ruthenium tetroxide (Swartzendruber et al,
1989). Samples were dehydrated in a graded series of alcohols and
embedded in Medcast-Araldite resin. Ultra-thin sections were prepared
on a Reichert-Jung Ultracut E, mounted on TEM grids, and examined
with a JEOL 100 CX II transmission electron microscope.
Immunohistochemistry Biopsies were collected from CSS grafts (0.0
or 0.1 mM vitamin C) on day 14 of in vitro incubation, and from healing
grafts at 8 wk after surgery. Tissue samples were frozen in M±1
Embedding Matrix (Lipshaw, Pittsburgh, PA) using a two-step process to
ensure proper orientation of the specimens. The biopsies were frozen ¯at
initially in a small volume of M±1 in a steel mold contacted to dry ice.
The embedded sample was removed from the mold and the block was
trimmed with a razorblade to reveal one edge of the tissue. The block
was rotated so the trimmed edge was down and held in place with
forceps in a steel mold ®lled with M±1 until freezing was initiated on
dry ice. The mold was transferred to a steel plate chilled with liquid
nitrogen and a plastic embedding ring was frozen to the mold with an
additional volume of M±1 to facilitate subsequent sectioning of the
frozen block. Cryostat sections (»15 mm) were dehydrated in methanol,
®xed in acetone, and stored at ±20°C until rehydration. After warming
to room temperature, sections were rehydrated in PBS at pH 7.6.
All washing, blocking, antibody incubation, and staining steps were
performed at room temperature. Speci®c primary antibodies and a
nonspeci®c negative control antibody (see below) were incubated for
30 min on sections from CSS grafts for identi®cation of basement
membrane proteins. The antibodies were detected by peroxidase labeling
with a Vectastain Universal Elite ABC Kit (#PK-6200; Vector
Laboratories, Burlingame, CA) followed by chromogenic visualization
with 3,3¢-diaminobenzidine (DAB) using a DAB Substrate Kit (#SK-
4100; Vector Laboratories). The manufacturer's protocol for frozen
sections was followed with minor modi®cations. To reduce electrostatic
charges on the sections a rinse (5 min) with PBS/0.05% Tween 20 (vol/
vol, pH = 7.6) was added prior to primary antibody incubation.
Endogenous peroxidase activity was quenched with a rinse (30 min) of
0.3% hydrogen peroxide following the biotinylated secondary antibody
incubation. All sections were counterstained with ®ltered Toluidine
Blue, rinsed, and coverslipped with Clearslip (#CS-160; IMEB,
SanMarcos, CA). The speci®c primary antibodies used were all murine
monoclonal antibodies against human basement membrane antigens:
collagen type IV (#MAB1910; Chemicon International, Temecula, CA)
diluted 1:500, collagen type VII (#MAB1345; Chemicon International)
diluted 1:500, laminin 5/kalinin (#MAS160; Harlan Sera-Lab Ltd.,
Loughborough, U.K.) diluted 1:20. The negative control antibody was a
monoclonal mouse IgG1 isotype control (#MAB002; R&D Systems,
Minneapolis, MN) used at a concentration of 2 mg per ml.
CSS engraftment to athymic mice was con®rmed by direct immuno-
¯uorescence staining of frozen sections collected at 8 wk after surgery. A
Figure 1. Vitamin C promotes more complete anatomy and structural assembly of epidermal barrier lipids in a CSS model on ®lter
membranes. (A), (C) 0.0 mM vitamin C. (B), (D) 0.1 mM vitamin C. At incubation day 14, the epithelial morphology of CSS is well strati®ed and
corni®ed in conditions with (A) 0.0 mM vitamin C or (B) 0.1 mM vitamin C. Fibroblast density in the dermal compartment, however, is greater in
the presence of vitamin C (arrow). TEM of intercorneocyte lipids at incubation day 14 shows poor organization of lamellar structures in (C) 0.0 mM
vitamin C, but lipid lamellae characteristic of stratum corneum in (D) 0.1 mM vitamin C. Scale bars: (A), (B) 0.160 mm; (C), (D) 50 nm.
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¯uorescein-labeled antibody (#MAS1532; Harlan Sera-Lab Ltd.) against a
common hapten of the HLA-ABC histocompatibility antigens
(Briggaman, 1985; Boyce et al, 1991) was used to detect human cells in
healed CSS grafts.
Surface electrical capacitance (SEC) Capacitance (SEC) represents a
measure of skin surface hydration, which is inversely proportional to the
electrical impedance (Boyce et al, 1996; Supp et al, 1999). The NOVA
Dermal Phase Meter (DPM 9003; NOVA Technology, Portsmouth,
NH) was used to collect SEC data from CSS grafts in vitro and from
healing CSS on athymic mice. An alternating current applied between
two electrodes at the skin surface enables the NOVA meter to detect an
electrical phase shift over time. The magnitude of the phase shift
increases as water moves through the stratum corneum and accumulates
beneath the capacitance probe, with a corresponding increase of the SEC
value. Therefore, CSS with a functional barrier yield low SEC values
and CSS with a poor barrier result in high SEC readings.
Ten serial readings at 1 s intervals were recorded from each CSS graft
in vitro (n = 3 per condition) on culture days 7, 12, 14, 19, 21, 26, 28,
32, and 35, and from healing grafts at 2, 3, 4, and 6 wk after surgery.
Six SEC measurements were taken from each CSS in vitro at each time
point (18 SEC values per condition), and three SEC measurements from
each healing CSS at each time point (24 or 27 SEC values per group).
The SEC data are expressed in picofarads as mean 6 SEM.
Measurement of wound contraction Direct tracings of wound
perimeters were made from CSS at the time of grafting (original area)
and at 2, 3, 4, 5, 6, and 8 wk after surgery. Image analysis (Image-1;
Universal Imaging, Downingtown, PA) of the wound perimeter tracings
was performed to determine wound area. Data for wound contraction
during CSS healing are expressed as a percentage of the original wound
area at the time of grafting as previously described (Boyce et al, 1995c,
1997; Supp et al, 1999). Data for each group are presented as mean 6
SEM.
Statistical analysis The MTT assay and BrdU incorporation data were
analyzed by one-way analysis of variance. The method used for multiple
comparisons was Student±Newman±Keuls and signi®cance was
established at the 95% con®dence level (p < 0.05). The SEC and wound
contraction data were analyzed using one-between, one-within repeated
measures analyses of variance (RM-ANOVA) to determine overall
differences between groups. Signi®cant pair-wise differences (p < 0.05)
were found by univariate ANOVA following RM-ANOVA.
RESULTS
Vitamin C promotes morphogenesis of epidermal barrier
and ®broblast proliferation in CSS As shown in Fig 1,
addition of 0.1 mM vitamin C to serum-free medium stimulates
epidermal maturation, and supports ®broblast survival and
proliferation. At day 14 of incubation (including 11 d of air
exposure), CSS without (Fig 1A) or with (Fig 1B) vitamin C have
well-strati®ed epidermal analogs. The keratinocyte strata are less
compacted, however, and the ®broblast population of the dermal
substitute is greater in the presence of vitamin C (Fig 1B). Very
importantly, TEM of the stratum corneum of the epidermal analog
showed sparse and poorly developed lipid lamellae in CSS at day 14
of incubation without vitamin C (Fig 1C), but with vitamin C the
characteristic broad-narrow lipid lamellae of epidermal barrier were
found (Fig 1D).
Vitamin C sustains DNA synthesis and mitochondrial
metabolism Measurements of cellular viability in vitro
demonstrated both vitamin-C-dependent and time-dependent
responses of DNA synthesis (BrdU incorporation) and
mitochondrial metabolism (MTT conversion). In Fig 2, BrdU-
positive keratinocytes in all conditions at incubation day 14 were
statistically greater than at day 35, but were not different from each
other. Therefore, at incubation day 14, there was no difference in
keratinocyte proliferation that was dependent on vitamin C, and a
general decrease of DNA synthesis in keratinocytes occurred in all
concentrations of vitamin C as a function of time. At incubation
day 35, a statistical difference in percentage BrdU-positive
keratinocytes was found between 0.0 mM (1.34 6 0.46) and
0.1 mM (7.19 6 1.19) vitamin C, but no other signi®cant
differences were found. This result demonstrates a concentration-
dependent response to vitamin C of DNA synthesis in CSS.
Substantial differences in mitochondrial metabolism were also
observed as shown in Fig 3. CSS without vitamin C demonstrated
a statistically signi®cant decrease in MTT conversion between day
14 (1.01 6 0.04) and day 35 (0.53 6 0.09), and this decrease was
reversed by addition of 0.1 mM (0.89 6 0.07) vitamin C to the
medium. No differences were found among any conditions at day
14, or among conditions containing vitamin C at day 35. These
results demonstrate that addition of 0.1 mM vitamin C to the
Figure 2. CSS with vitamin C synthesize more DNA. Scoring of
BrdU positive keratinocytes at day 14 and day 35 of incubation in vitro
shows no differences among conditions at incubation day 14. All
conditions at day 14 were greater than corresponding conditions at day
35 (*). At incubation day 35, 0.1 mM vitamin C supports greater
incorporation of BrdU than 0.0 mM vitamin C (#).
Figure 3. Vitamin C supports higher levels of MTT conversion in
a CSS model on ®lter membranes at incubation day 35 in vitro. In
0.0 mM vitamin C, a statistically signi®cant decrease of MTT conversion
occurs between incubation day 14 and 35, which is reversed by 0.1 mM
vitamin C.
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culture medium can maintain basal cellular metabolism for 1 mo or
longer.
Vitamin C promotes development of basement
membrane Expression and organization of basement
membrane antigens is greatly stimulated by addition of vitamin C
to the medium as shown in Fig 4. In the absence of vitamin C, the
same antigens were expressed speci®cally, but a reticulated pattern
of staining extended down from the basement membrane zone into
the dermal substitute (Fig 4A, C, E). CSS incubated for 14 d in
medium containing 0.1 mM vitamin C showed distinct linear
staining of collagen VII (Fig 1B), collagen IV (Fig 1D), and
laminin 5 (Fig 1F). No staining was observed in the control
samples without (Fig 1G) or with (Fig 1H) vitamin C, which
were reacted with a nonspeci®c monoclonal antibody. Another
general observation between the conditions was that addition of
vitamin C supported a much denser population of ®broblasts, and a
more histiotypic epithelium.
Figure 4. Basement membrane forms in CSS in vitro at incubation day 14. (A), (C), (E), (G) 0.0 mM vitamin C. (B), (D), (F), (H) 0.1 mM
vitamin C. (A), (B) Collagen VII; (C), (D) collagen IV; (E), (F) laminin 5; (G), (H) negative control. Addition of vitamin C to incubation medium
supports organization of these basement membrane antigens into linear structures at the dermal±epidermal junction of CSS. Scale bars: 0.128 mm.
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Vitamin C maintains epidermal barrier formation and
mitochondrial metabolism in vitro Measurement of SEC
before grafting is shown in Fig 5(A). Statistically lower SEC was
found for 0.1 mM vs 0.0 mM vitamin C, and was observed at
incubation days 7, 32, and 35 (Fig 5A). These results indicate that
vitamin C in the culture medium stimulates more rapid formation
of epidermal barrier, and maintains the barrier for a longer period of
time. At day 35 of incubation, MTT was statistically greater in CSS
incubated with 0.1 mM vitamin C (OD590 0.90 6 0.06) than
without vitamin C (OD590 0.46 6 0.02). Differences in cellular
morphology were more subtle at incubation day 35. In the absence
of vitamin C, an analog of stratum corneum forms, and nucleated
keratinocytes are attached to the dermal substitute (Fig 5B), but
the staining of the samples with Toluidine Blue is pale in
comparison to equivalent sections from CSS incubated in vitamin
C (Fig 5C). There was also a subjective difference that CSS have
greater ®broblast density with vitamin C than without vitamin C.
Vitamin C promotes wound closure and reduces wound
contraction CSS incubated in vitamin C stimulated more rapid
restoration of epidermal barrier at 2 or 3 wk after grafting to
athymic mice (Fig 6A). At these time points, grafted CSS
incubated in vitro with vitamin C had SEC values that were not
different statistically from uninjured human skin. These results
suggest that incubation of CSS in vitamin C promotes formation of
epidermal barrier for more rapid wound closure. The bene®ts of
vitamin C on wound contraction are shown in Fig 6(B). Wounds
treated with CSS incubated in 0.1 mM vitamin C remained
statistically larger between 2 and 4 wk after grafting, demonstrating
a delay in wound contraction. Mean wound area was greater at all
time points up to 8 wk after grafting of CSS incubated in vitamin
C. These responses may be attributed to the greater viability,
epidermal barrier, and basement membrane formation in CSS
incubated in vitamin C. It was also found that greater numbers of
healed wounds stained positively for HLA-ABC after grafting with
CSS incubated in 0.1 mM vitamin C (seven out of nine, 78%) than
in 0.0 mM vitamin C (four of eight, 50%).
DISCUSSION
Data reported here demonstrate that addition of vitamin C to
incubation media improves the anatomy and physiology of CSS
before grafting, and improves wound healing after grafting.
Multiple bene®ts were found, including improvement of epidermal
barrier, increased metabolic viability, greater DNA synthesis, and
decreased wound contraction during the early phase of healing.
The data support the intuitive postulate that improvements in
wound healing should result from skin grafts with greater
homology to native skin. Perhaps the most important of the
physiologic advantages resulting from addition of vitamin C to
incubation media is the sustained proliferation of keratinocytes in
CSS for periods up to 5 wk. Without keratinocyte proliferation,
there would be no expectation of stable wound closure. Results of
this study also show early development of basement membrane
antigens including collagen IV, collagen VII, and laminin 5. The
regulatory actions of these basement membrane proteins on
keratinocyte proliferation are well understood (Streuli et al, 1995;
Lelievre et al, 1996), and account in part for the sustained DNA
synthesis of keratinocytes by vitamin C that was observed in this
study.
Vitamin C supported retention of cellular viability (BrdU, MTT)
for up to 5 wk of incubation (Figs 2, 3). DNA synthesis in
keratinocytes decreased between days 14 and 35 in all conditions
tested, but was signi®cantly greater in 0.1 mM vitamin C than
0.0 mM vitamin C at day 35. This demonstrates that the general
rate of keratinocyte proliferation decreases over time, but is
maintained at a higher level by vitamin C. The retention of
keratinocyte proliferation is believed to relate directly to the
ef®cacy of CSS to engraft and persist after transplantation.
Therefore, although the absolute differences between 0.0 and
0.1 mM vitamin C seem small, the retention of a proliferative
Figure 5. SEC and microscopic anatomy demonstrate epidermal
barrier formation. (A) Expressed as picofarads (pF), CSS demonstrate
statistically lower SEC after incubation in 0.1 mM than in 0.0 mM
vitamin C at incubation days 7, 32, and 35 in vitro. At day 35 of
incubation, MTT was statistically greater in CSS incubated with vitamin
C (OD590 0.90 6 0.06) than without vitamin C (OD590 0.46 6 0.02).
Microscopic anatomy of CSS showed no obvious differences between
incubation in vitamin C at 0.0 mM (B) or 0.1 mM (C) concentrations.
Scale bars: 0.128 mm.
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population of keratinocytes promotes permanent closure of treated
wounds. Absolute differences in MTT values were smaller as a
function of time for two possible reasons. First, the measurement of
MTT included both ®broblasts and keratinocytes, and the ®broblast
component may maintain a higher metabolic rate than the
epidermal component. Second, MTT measures mitochondrial
metabolism, which is an index of cellular viability rather than
proliferation. Therefore, the differences in absolute values between
BrdU and MTT illustrate the simultaneous decrease in proliferation
rate and retention of metabolic rate in the presence of vitamin C.
Both measures, however, recorded statistically greater cellular
viability as a function of vitamin C in the medium.
Greater ef®cacy of wound healing by CSS incubated in vitamin
C was measured by more stable formation of epidermal barrier
(Fig 5A), and more rapid wound closure and less wound
contraction after grafting (Fig 6). These results emphasize the
importance of cellular physiology at the time of grafting, and verify
the retention of potency of CSS for up to 5 wk as a function of
vitamin C. This extension of viability by nutritional regulation
translates into greater availability and longer storage of cultured skin
grafts for clinical applications in surgery and dermatology.
Nutritional de®ciency of vitamin C results in scurvy, which is
characterized by cutaneous lesions resulting from dermal and
epidermal atrophy (Hirschmann and Raugi, 1999). CSS without
vitamin C exhibit metabolic and physiologic symptoms of scurvy
including de®cient epithelial attachment, reduced development of
the connective tissue component, and defective epidermal barrier.
In the presence of vitamin C, it was also noted qualitatively after
5 wk incubation that ®broblasts in CSS were much more
numerous than without vitamin C. This observation is consistent
with other studies that have reported the stimulation of ®broblast
proliferation and collagen synthesis by vitamin C (Barnes, 1975;
Prockop et al, 1979). Although not measured in this study, it may
be inferred that synthesis of collagen, carbohydrate-based extra-
cellular matrix (e.g., hyaluronic acid, GAG), and peptide cytokines
(e.g., basic ®broblast growth factor, insulin-like growth factors) are
also increased by the availability of vitamin C to cells in CSS. The
multiple and broad responses of CSS to vitamin C in vitro also
suggest that it serves as a cofactor in a general biochemical activity
(i.e., hydroxylation) for virtually all metabolic pathways in which
that activity occurs. The result is much greater vitality and stability
of the CSS, and correction of the nutritional de®ciency that leads to
the symptoms of scurvy. Although scurvy has historically been
viewed as a connective tissue disease, it may also be considered that
de®ciency of vitamin C causes a direct block in the biochemical
pathway to the formation of epidermal barrier by keratinocytes.
Earlier studies from this laboratory and others had determined
that epidermal barrier in CSS was de®cient, but barrier function
was restored after grafting to experimental wounds (Boyce et al,
1991; Higounenc et al, 1994; Vicanova et al, 1998) or clinical burns
(Gallico et al, 1984; Boyce et al, 1993b). This observation is also
explained, in part, by the availability of vitamin C in wounds of
well-nourished recipients. It was also noted, however, that the time
required to form functional epidermal barrier and accomplish
wound closure was 2 wk or more. Conversely, if functional
epidermal barrier forms in vitro, then biologic wound closure occurs
at the time of grafting and becomes stable after vascularization of
the graft. Clinical studies with CSS incubated in vitamin C have
shown anecdotally that formation in vitro of epidermal barrier and
stronger epithelial±mesenchymal attachments in CSS result in
formation of functional epidermal barrier within 1 wk after grafting
(Boyce et al, 1999). Additional studies are planned to verify and
quantify those observations.
Continued progress in development of advanced therapies for
treatment of full-thickness skin wounds can be expected to result
from availability of a laboratory-generated skin graft with
homology to healthy human skin. Results of this study suggest
that medium conditions in which cellular metabolism approaches
normal both qualitatively and quantitatively will contribute to CSS
with greater clinical ef®cacy. Greater availability, stability, and
ef®cacy of CSS may be expected to contribute to reduction of
morbidity and mortality from cutaneous wounds.
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Figure 6. Vitamin C promotes barrier formation and reduces
wound contraction during wound healing. (A) More rapid
formation of epidermal barrier and wound closure is demonstrated by
statistically lower SEC values for CSS incubated in 0.1 mM than in
0.0 mM vitamin C at 2 and 3 wk after grafting of CSS to athymic mice.
(B) Statistically less wound contraction was found at postoperative week
2, 3, and 4 for CSS incubated in 0.1 mM vitamin C than in 0.0 mM
vitamin C. Mean values for CSS incubated in 0.1 mM vitamin C
remained higher through 8 wk after grafting to athymic mice. Greater
numbers of healed wounds stained positively for HLA-ABC after grafting
with CSS incubated in 0.1 mM vitamin C (seven out of nine, 78%) than
in 0.0 mM vitamin C (four out of eight, 50%).
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